AX-024 is primarily researched for its potential therapeutic applications in the field of immunology. It is being studied as a modulator of T-cell function, which plays a critical role in the immune system's response to infections and diseases. By targeting specific signaling pathways, AX-024 has shown promise in enhancing immune responses, making it a candidate for treating autoimmune disorders and certain types of cancer. Additionally, its ability to regulate T-cell activity could be leveraged in the development of novel immunotherapies, offering a new approach to managing conditions where the immune system is either overactive or underactive. Ongoing research aims to further explore its efficacy and safety in clinical settings.